巨子 ICON - 財經股票資訊及專家分析
搜尋 股票

Oramed Pharmaceuticals

ORMP
最少15分鐘延遲,股票資訊由第三方資訊供應商提供
・Oramed Pharmaceuticals - 延遲價格・最後更新於 14/01 12:14
最高位
11.240
最低位
10.720
開市價
--
前收市價
10.930
成交量(千)
44.54
成交額(百萬)
4.24
買入
--
賣出
--
每手股數
--
市值(百萬)
422.27
市盈率
--
息率
--
差價
--
52週高低
31.540 - 4.120
所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

企業資料

公司名稱
Oramed Pharmaceuticals
證券代碼
ORMP.US
所屬板塊
Biotechnology
公司業務
Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.
發行量
38086020
公司總部
1185 Avenue of the Americas, Suite 228, Third Floor
公司網址
https://www.oramed.com
公司電郵
info@oramed.com
公司電話
+1 844 967-2633
暫無內容

關於

Oramed Pharmaceuticals(ORMP.US)所屬的行業板塊為Biotechnology。
Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.
詳細公司背景可參考: https://www.oramed.com